Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

21.4%

3 terminated/withdrawn out of 14 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

36%

5 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(37.5%)
Phase 4
3(37.5%)
Phase 3
2(25.0%)
8Total
N/A(3)
Phase 4(3)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT06844318Recruiting

Impact of IBD Activity on Frailty in Patients Over 60 Years

Role: lead

NCT05698745Recruiting

Immunological Characteristics of Preclinical IBD

Role: lead

NCT07248644Phase 4Not Yet Recruiting

Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission

Role: lead

NCT06031038Not ApplicableCompleted

Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU

Role: lead

NCT05271773Completed

Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis

Role: lead

NCT04330846Not ApplicableRecruiting

Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease.

Role: lead

NCT02921555Phase 4Terminated

Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis

Role: lead

NCT06469424Recruiting

An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)

Role: lead

NCT02904590Completed

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease

Role: lead

NCT03894228Recruiting

Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)

Role: lead

NCT02395354Not ApplicableUnknown

Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease

Role: lead

NCT01562951Phase 3Terminated

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants

Role: lead

NCT00702611Phase 4Terminated

Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis

Role: lead

NCT01564823Phase 3Completed

Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease

Role: lead

All 14 trials loaded